Home » Topics » Regulatory

Regulatory
RSS

New indication for Sandostatin injection approved in Japan

Oct. 29, 2004

European approval for Emselex

Oct. 28, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Lundbeck files for new Alzheimer's indication for Ebixa in Europe

Oct. 25, 2004

Remicade receives European approval for psoriatic arthritis

Oct. 19, 2004

Approval for new Cancidas indication

Oct. 15, 2004

European approval for Protelos

Oct. 6, 2004

Abilify approved for acute bipolar mania

Oct. 5, 2004

FDA approves Remicade as first-line therapy in moderate to severe RA

Oct. 5, 2004

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...